Finance

Lists
Q1 2027 earnings • released • EPS miss -28.07% • Revenue beat +3.87%
See results
ROSSARI:NSE
Rossari Biotech Ltd
₹493.60
-0.62%
(-3.10) 1D
Jul 23, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ROSSARI...
Open
₹496.95
High
₹500.50
Low
₹490.10
Mkt. cap
27.34B
Avg. vol.
117.11K
Volume
28.24K
Dividend
0.10%
Quarterly dividend
₹0.12
Ex-dividend date
Jul 10, 2026
P/E ratio
18.15
52-wk high
₹728.95
52-wk low
₹375.00
EPS
₹27.20
No. of employees
585
Open
₹496.95
High
₹500.50
Low
₹490.10
Mkt. cap
27.34B
Avg. vol.
117.11K
Volume
28.24K
Dividend
0.10%
Quarterly dividend
₹0.12
Ex-dividend date
Jul 10, 2026
P/E ratio
18.15
52-wk high
₹728.95
52-wk low
₹375.00
EPS
₹27.20
No. of employees
585
News stories
From sources across the web
Profile
Rossari Biotech is an Indian chemical manufacturing company with a focus on specialty chemicals. It is also engaged in production of specialty enzymes and chemicals in India that is used in the pharmaceuticals, paper, construction, textiles, nutrition and animal health industries. The company was started in 2003 as a partnership firm titled Rossari Labtech and was incorporated into a company in 2009 and was renamed as Rossari Biotech. It has two R&D facilities, one at Silvassa manufacturing facility and the second in Dahej. Wikipedia
About Rossari Biotech Ltd
CEO-
Employees585
FoundedAug 10, 2009
Headquarters-
SectorSpeciality chemicals
Websiterossari.com
Last report
Jul 20, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹6.33 / ₹8.80
-28.07%miss
Revenue / Est. (INR)
6.97B / 6.71B
+3.87%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.86B
5.82B
6.85B
6.97B
Cost of goods sold
4.01B
4.01B
5.04B
4.91B
Cost of revenue
4.01B
4.01B
5.04B
4.91B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
377.99M
402.56M
463.26M
440.44M
Operating expense
1.32B
1.32B
1.44B
1.51B
Total operating expenses
5.32B
5.32B
6.48B
6.42B
Operating income
536.91M
492.59M
369.04M
550.05M
Other non operating income
16.04M
5.09M
-27.71M
31.87M
EBT including unusual items
496.72M
425.01M
642.43M
476.72M
EBT excluding unusual items
496.72M
425.01M
437.87M
476.72M
Income tax expense
127.96M
97.27M
182.76M
125.77M
Effective tax rate
25.76%
22.89%
28.45%
26.38%
Other operating expenses
755.29M
717.50M
736.59M
817.11M
Net income
368.76M
327.74M
459.67M
350.95M
Net profit margin
6.29%
5.63%
6.71%
5.03%
Earnings per share
6.65
5.91
8.29
6.33
Interest and investment income
-
-
13.51M
-
Interest expense
-60.91M
-76.65M
-90.59M
-109.77M
Net interest expenses
-60.91M
-76.65M
-77.08M
-109.77M
Depreciation and amortization charges
182.33M
196.14M
235.28M
256.15M
EBITDA
716.82M
645.98M
544.80M
725.80M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer